NASDAQ Stocks Hitting 52-Week Highs (CLDA, DEPO, CPSI, NPSP)

Clinical Data Inc CLDA shares gained 3.12% to create a new 52-week high of $28.22. CLDA shares have advanced 78.01% over the past 52 weeks, while the S&P 500 index has gained 18.85% in the same period. Depomed Inc DEPO shares surged 30.45% to create a new 52-week high of $8.14. The Food and Drug Administration (FDA) has approved DEPO's Gralise one-daily tablets for the treatment of post-herpetic neuralgia. Computer Programs and Systems Inc CPSI shares rose 2.60% to create a new 52-week high of $52.16. CPSI reported 85.3% y/y surge in its Q4 net income. NPS Pharmaceuticals Inc NPSP shares gained 25.89% to create a new 52-week high of $9.58. A Phase 3 trial of NPSP's drug GATTEX found that it reduced parenteral nutrition dependence in patients with adult short bowel syndrome. Read more from Benzinga's Markets.